OpenVSafe by OpenVAERS
Search V-safe

72P-28597-38410

2 vaccinations 8 coded responses 24 check-ins 8 free-text entries 0 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
982 / WA
Registered
2021-01-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-19
    Registered in v-safe
  2. 2021-01-19
    Dose 1 — Moderna
  3. 2021-01-19
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · None
    Adult check-in
  5. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · None
    Adult check-in
  6. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  8. 2021-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-28
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-09
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-16
    Dose 2 — Moderna
  13. 2021-02-16
    Health check-in — day 0, dose 2
    Feeling: Fair · None
    Adult check-in
  14. 2021-02-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Carpal tunnel syndrome, Condition aggravated, Pain — Feeling: Poor · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: All of my neuro/muscular (carpal tunnel type) have flared to high intensity. Set off with very minor muscular use. Very high pain.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Arthralgia, Pre-existing disease, Stress — Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Acute sensitivity to stress in body joints. Accelerated onsets, higher than normal pain levels,
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Redness, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  17. 2021-02-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  18. 2021-02-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  19. 2021-02-23
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  20. 2021-03-02
    Survey response — day 14, dose 2
    MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Exhaustion. Inability to recover enough during normal sleep.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-03-09
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-16
    Survey response — day 28, dose 2
    MedDRA: Arthralgia, Asthenia, Cough, Myalgia, Photosensitivity reaction, Sneezing — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Coughing, dry throat, sun sensitivity and violent sneezing. Joint and muscle pain. Moderate loss of strength.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-03-23
    Survey response — day 35, dose 2
    MedDRA: Arthralgia, Fatigue, Muscular weakness, Myalgia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Exhaustion, weakening strength, lower threshold for stress induced muscle and joint pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-03-30
    Survey response — day 42, dose 2
    MedDRA: Balance disorder, Fall, Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Exhaustion, Loss of balance, falling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-05-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-08-19
    Survey response — 6 months, dose 2
    MedDRA: Arthralgia, Asthenia, Fatigue, Gait disturbance — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Heavier fatigue, joint pain, especially fingers, hands and shoulders, weaker everywhere, especially walking endurance.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  27. 2022-02-16
    Survey response — 12 months, dose 2
    MedDRA: Arthralgia, Asthenia, Cough, Fatigue, Hypoacusis, Myalgia, Oropharyngeal pain, Pain, Respiratory tract congestion, Sneezing — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Exhaustion, cough, sneezing, sore throat, body ache and pain. Joint pain, muscle pain, heavy congestion, trouble hearing, weakness.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-01-19Moderna
22021-02-16Moderna

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-17

Systemic reaction (other): All of my neuro/muscular (carpal tunnel type) have flared to high intensity. Set off with very minor muscular use. Very high pain.

2021-02-18

Systemic reaction (other): Acute sensitivity to stress in body joints. Accelerated onsets, higher than normal pain levels,

Release 4 — day 14, dose 2

2021-03-02

Symptoms: Exhaustion. Inability to recover enough during normal sleep.

Release 5 — day 28, dose 2

2021-03-16

Symptoms: Coughing, dry throat, sun sensitivity and violent sneezing. Joint and muscle pain. Moderate loss of strength.

Release 6 — day 35, dose 2

2021-03-23

Symptoms: Exhaustion, weakening strength, lower threshold for stress induced muscle and joint pain

Release 6 — day 42, dose 2

2021-03-30

Symptoms: Exhaustion, Loss of balance, falling

Release 9 — 6 months, dose 2

2021-08-19

Symptoms: Heavier fatigue, joint pain, especially fingers, hands and shoulders, weaker everywhere, especially walking endurance.

Release 11 — 12 months, dose 2

2022-02-16

Symptoms: Exhaustion, cough, sneezing, sore throat, body ache and pain. Joint pain, muscle pain, heavy congestion, trouble hearing, weakness.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDAsthenia ✓ ✓ ✓
SDBalance disorder ✓ ✓ ✓
SDCough ✓ ✓ ✓
SDFall ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDGait disturbance ✓ · ✓
SDHypoacusis · · ✓
SDMuscular weakness ✓ ✓ ✓
SDMyalgia ✓ ✓ ✓
SDOropharyngeal pain · · ✓
SDPain · · ✓
SDPhotosensitivity reaction ✓ ✓ ✓
SDRespiratory tract congestion · · ✓
SDSneezing ✓ ✓ ✓
SROArthralgia ✓ ✓ ✓
SROCarpal tunnel syndrome ✓ ✓ ✓
SROCondition aggravated ✓ ✓ ✓
SROPain ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROStress ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release